Thyme Care
Thyme Care is an oncology management company providing personalized support to cancer patients through technology and a dedicated care team.
Secondary Market Price
How Thyme Care Measures Up
To help you manage your Thyme Care equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series D
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Thyme Care's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Thyme Care Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Thyme Care's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Thyme Care is a value-based care enabler focused on the oncology sector. The company partners with health plans, employers, and providers to improve health outcomes and reduce the total cost of care for individuals with cancer. Its approach uses a technology-enabled care team that integrates with its network of over 800 oncologists, called Thyme Care Oncology Partners. This model provides personalized support and coordination for patients, using a combination of human guidance, software, and analytics. Founded in 2020, the company is headquartered in Nashville, TN.
Looking forward, Thyme Care is expanding its services and presence, with a particular focus on states like North Carolina, and is actively hiring for multiple teams. A recent partnership with Premera Blue Cross expands the insurer's Personal Health Support program by giving members 24/7 access to Thyme Care's oncology-trained team. At one partner location, this team handled 1,129 inbound calls from patients over a five-month period. Thyme Care is also a founding member of CancerX, an initiative focused on cancer innovation. The company's most recent funding was a Series D round.
- CVS Health Ventures
- Foresite Capital
- a16z Bio + Health
- Concord Health Partners
- Town Hall Ventures
- AlleyCorp
- Frist Cressey Ventures
- Morgan Health
- Humana
- Texas Oncology
- Memorial Hermann Health System
- Co-Founder, Chief Executive Officer Robin Shah
- Co-Founder, President, and Chief Medical Officer Bobby Green
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Thyme Care worth joining?
Deciding to join a startup like Thyme Care involves evaluating many factors, including the potential of your equity compensation. Platforms like Prospect can help you understand and forecast the value of your equity to make a more informed decision.
What should I do with my Thyme Care stock?
Managing stock in a private company like Thyme Care requires careful planning around exercising options and minimizing taxes. Using a service like Prospect can provide customized strategies for when to exercise and sell your shares to maximize their value.
Can you sell Thyme Care stock?
Selling stock in a private company like Thyme Care is possible but typically restricted to specific events like tender offers or secondary market sales. Tools offered by platforms such as Prospect can help you navigate these opportunities and determine the most tax-efficient shares to sell.
How can I find the value of my Thyme Care stock?
Valuing stock in a private company like Thyme Care is challenging because it doesn't trade on public markets. Prospect uses predictive models and secondary market data to help you project the future value of your private company shares.
What is Thyme Care's equity worth?
The precise worth of Thyme Care's equity depends on the company's valuation, but its true value to you also accounts for taxes and exercise costs. Services like Prospect help calculate the net value of your equity by modeling these complex financial variables.
What is Thyme Care's stock ticker symbol?
As a private company, Thyme Care does not have a stock ticker symbol because its shares are not traded on a public stock exchange. A ticker symbol would only be assigned if the company were to go public through an Initial Public Offering (IPO).
Can I buy or sell Thyme Care stock?
Buying stock in a private company like Thyme Care is generally restricted to accredited investors or employees, while selling is limited to specific windows like tender offers. If you are an employee, platforms like Prospect provide tools to help you decide when and how much to sell for optimal financial outcomes.
What is the criteria to buy or invest in Thyme Care stock?
Investing in a private company like Thyme Care is typically limited to accredited investors participating in funding rounds or buying on secondary markets. Employees can also acquire shares by exercising their stock options, a process that platforms like Prospect help optimize for tax efficiency and timing.
